Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995
- 1 July 1988
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 75 (7) , 718
- https://doi.org/10.1002/bjs.1800750732
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of the Somatostatin Analogue Sandostatin (SMS 201–995) on Gastrointestinal, Pancreatic and Biliary Function and Hormone Release in Normal MenDigestion, 1987
- Effect of a New Somatostatin Analogue on Pancreatic Function in Healthy VolunteersPancreas, 1986
- Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of SomatostatinScandinavian Journal of Gastroenterology, 1986
- Gastrointestinal somatostatin: Distribution, secretion and physiological significanceLife Sciences, 1985
- SOMATOSTATIN TREATMENT OF GASTROINTESTINAL FISTULAS: EVIDENCE FOR A REBOUND EFFECT ON WITHDRAWALAnz Journal of Surgery, 1984
- SOMATOSTATIN IN PERSISTENT GASTROINTESTINAL FISTULA TREATED BY TOTAL PARENTERAL NUTRITIONThe Lancet, 1982
- Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*Journal of Clinical Endocrinology & Metabolism, 1979
- Effects of somatostatin on the exocrine pancreas and the release of duodenal hormonesMetabolism, 1978
- Effects of Somatostatin on Exocrine and Endocrine Pancreatic Function Stimulated by Intestinal Hormones in ManHormone and Metabolic Research, 1976
- Somatostatin Suppresses Secretin and Pancreatic Exocrine SecretionScience, 1975